Case Report
Published on 11 Jan 2024
Case report: Apalutamide-induced severe lethal cutaneous adverse effects in China
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1291564
- 101 views
Type at least 3 characters
5,330 articles
Articles
Original Research
Accepted on 10 Jan 2024
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1346686
Review
Accepted on 10 Jan 2024
Landscape of adenosine pathway and immune checkpoint dual blockade in NSCLC: pr ogr ess in basic r esear ch and clinical application
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1320244
Case Report
Accepted on 10 Jan 2024
From Palliative to Potentially Curative -The Advent of Immunotherapy Providing Hope to Advanced Gallbladder Adenocarcinoma: Case Description and Review of Literature
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1353430
Original Research
Accepted on 10 Jan 2024
Increased circulating regulatory T cells and decreased follicular T helper cells are associated with colorectal carcinogenesis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1287632
Original Research
Accepted on 10 Jan 2024
Molecular and immunological features of TREM1 and its emergence as a prognostic indicator in glioma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1324010
Original Research
Published on 10 Jan 2024
Exploring KRAS-mutant pancreatic ductal adenocarcinoma: a model validation study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1203459
- 248 views
Original Research
Published on 10 Jan 2024
Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1295218
- 669 views
Original Research
Published on 10 Jan 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1326078
- 378 views
Review
Published on 10 Jan 2024
Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1325615
- 383 views
Correction
Published on 10 Jan 2024
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1349296
- 146 views
Original Research
Accepted on 09 Jan 2024
Exploring Aryl Hydrocarbon Receptor Expression and Distribution in the Tumor Microenvironment, with a Focus on Immune Cells, in Various Solid Cancer Types
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1330228
Original Research
Accepted on 09 Jan 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1353889
Original Research
Published on 09 Jan 2024
Development of a prognostic Neutrophil Extracellular Traps related lncRNA signature for soft tissue sarcoma using machine learning
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1321616
- 376 views
Perspective
Published on 09 Jan 2024
Limitations and potential of immunotherapy in ovarian cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1292166
- 532 views
Original Research
Published on 09 Jan 2024
Major vault protein regulates tumor-associated macrophage polarization through interaction with signal transducer and activator of transcription 6
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1289795
- 186 views